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Early Diagnosis of Multiple Endocrine Neoplasia Type 2B: 
a Challenge for Physicians
ABSTRACT
Background: The hereditary form of medullary thyroid carcinoma may occur 
isolated as a familial medullary thyroid carcinoma (FMTC) or as part of Mul-
tiple Endocrine Neoplasia 2A (MEN2A) and 2B (MEN2B). MEN2B is a rare 
syndrome, its phenotype may usually, but not always, be noted by the physi-
cian. In the infant none of the MEN2B characteristics are present, except by 
early gastrointestinal dysfunction caused by intestinal neuromas. When avail-
able, genetic analysis confi rms the diagnosis and guides pre-operative evalu-
ation and extent of surgery. Here we report four cases of MEN2B in which the 
late diagnosis had a signifi cant impact in clinical evolution and, potentially, in 
overall survival. Case Report: We report four cases, 2 men and 2 women, with 
differences in their phenotypes and with a late diagnosis. The fi rst case has a 
history of severe gastrointestinal obstruction requiring a surgery intervention 
two days after his birth. The second told had nodules in the oral mucosa and 
constipation since childhood. The third case referred a history of constipation 
from birth until 5 months of life. The fourth has had a history of chronic con-
stipation since childhood. Discussion: New concepts have emerged since the 
RET oncogene was identifi ed in 1993 as the responsible gene for hereditary 
medullary thyroid carcinoma. The majority of MEN2B individuals have M918T 
mutation in the exon 16 of RET, with a few cases having a mutation A883F or 
the association of V804M with E805K, Y806C or S904C mutations. The con-
sensus classifi es the RET mutation in codon 918 as of highest risk and recom-
mends total thyroidectomy and central lymph node dissection until 6 months 
after birth. A fast and precise diagnosis is essential to reach these goals. The 
identifi cation of early manifestations such as intestinal ganglioneuromatosis 
and oral mucosal neuromas should prompt the physician to initiate an inves-
tigation for multiple endocrine neoplasia type 2B. Conclusion: The diagnosis 
of MEN2B is very important to allow appropriate investigation of associated 
diseases and to allow counseling and appropriate screening of relatives for a 
RET mutation. Even patients with MEN2B, which often have typical physical 
features, may not be properly recognized and be followed as a sporadic 
case. Based on this, all suspicious cases of multiple endocrine neoplasia 
should undergo a molecular genetic test. (Arq Bras Endocrinol Metab 2008; 
52/8:1393-1398)
Keyword: Medullary thyroid carcinoma; MEN2B; M918T; Phenotype and in-
testinal ganglioneuromatosis
RESUMO
Diagnóstico Precoce de Neoplasia Endócrina Múltipla Tipo 2B: um Desafi o 
para os Médicos.
A forma hereditária do carcinoma medular da tiróide pode ocorrer de modo 
isolado, o carcinoma medular da tiróide familiar (FMTC), ou como parte das 
neoplasias endócrinas múltiplas tipo 2A (MEN2A) e 2B (MEN2B). MEN2B é 
uma síndrome rara e seu fenótipo é usualmente, mas nem sempre, notado 
pelo médico. Na infância, nenhuma das características de MEN2B estão pre-
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sentes, exceto pela disfunção gastrintestinal precoce, causada pelos neuromas 
intestinais. Quando disponível, a análise genética confi rma o diagnóstico e 
orienta a avaliação pré-operatória e extensão da cirurgia. Neste artigo, apre-
sentamos quatro casos de MEN2B, nos quais o diagnóstico tardio teve impacto 
signifi cativo na evolução clínica e, potencialmente, na mortalidade em geral. 
Apresentação dos casos: Apresentamos quatro casos, dois homens e duas 
mulheres, com diferenças em seus fenotipos e com diagnóstico tardio. O 
primeiro caso tem história de obstrução gastrintestinal importante em que foi 
necessária cirurgia dois dias após o nascimento. O segundo paciente apresen-
tava nódulos na mucosa oral e constipação desde a infância. O terceiro referia 
história de constipação desde o nascimento até 5 meses de idade. O quarto 
tinha história de constipação intestinal desde a infância. Discussão: Novos con-
ceitos emergiram desde que o oncogene RET foi identifi cado, em 1993, como 
o gene responsável pelo carcinoma medular da tiróide hereditário. A maioria 
dos indivíduos apresenta a mutação M918T no éxon 16 do RET, enquanto pou-
cos casos apresentam a mutação A883F ou a associação de V804M com E805K, 
Y806C ou S904C. O consenso recomenda a tiroidectomia total com dissecção 
dos linfonodos no compartimento central até os 6 meses após o nascimento. O 
diagnóstico rápido e preciso é essencial para o atingir os objetivos. Conclusão: 
O diagnóstico precoce de MEN2B é muito importante para propiciar a investi-
gação apropriada de doenças associadas e para permitir aconselhamento e 
rastreamento dos parentes para uma mutação do RET. Pacientes com MEN2B, 
que apresentam frequentemente achados típicos ao exame físico, podem não 
ser reconhecidos e seguidos como casos esporádicos. Por causa disso, todos 
os casos de neoplasia endócrina múltipla devem ser avaliados pelo teste gené-
tico para mutações do RET. (Arq Bras Endocrinol Metab 2008; 52/8:1393-1398)
Descritores: Carcinoma medular de tiróide; MEN2B; M918T; Fenótipo; Gan-
glioneuromatose intestinal
INTRODUCTION
The hereditary form of medullary thyroid carcinoma may occur isolated as a familial medullary thyroid 
carcinoma (FMTC) or as part of Multiple Endocrine 
Neoplasia 2A (MEN2A) and 2B (MEN2B). The Multi-
ple Endocrine Neoplasia 2B represents an inherited au-
tosomal dominant syndrome characterized by medullary 
thyroid carcinoma, pheochromocytoma, mucosal neu-
romas, ganglioneuromatosis of the gut and marfanoid 
habitus (1). Although MEN2B is a rare syndrome, its 
phenotype may usually, but not always, be noted by the 
physician.
The clinical diagnosis of MEN2B may be facilitated 
by the identifi cation of a characteristic phenotype whi-
ch includes distinctive facial features such as  thickened 
lips and elongated face, a “marfanoid” body habitus, 
mucosal neuromas (of lips, buccal mucosa, tongue, 
eyelids, palate and intestinal mucous membrane), thi-
ckened medullated corneal nerves (on slitlamp exami-
nation), skeletal abnormalities (kyphoscoliosis, joint 
laxity and pes cavus) in addition to medullary carcinoma 
of the thyroid and pheochromocytoma (2) (Table 1). 
Table 1. List of signs and symptoms of MEN2B and their fre-
quencies.
Clinical characteristics Frequency
Mucosal neuromas of the lips, eyelids, 
buccal mucosa, tongue, palate and 
intestinal mucous membrane (earliest sign)
100%
Enteric Ganglioneuromatosis 100%
Medullary carcinoma of the thyroid (very 
young child)
90%
Skeletal abnormalities of the spine (lordosis, 
kyphosis, scoliosis), talipes equinovarus, 
kyphoscoliosis, joint laxity and) and pes 
cavus
common
Thickened medullated corneal nerves 
(slitlamp examination)
Facies with thickened lips
Marfanoid habitus 65-75%
Pheochromocytoma 45-50%
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On the other hand, in the infant, none of these 
characteristics are present, except by early gastrointesti-
nal dysfunction caused by intestinal neuromas (3). In-
testinal ganglioneuromatosis can lead to severe 
constipation and megacolon simulating Hirschsprung’s 
disease (4-7). In fact, Hirschsprung’s disease may also 
occur with MEN2B (8).
The early onset and aggressiveness of medullary 
thyroid cancer in MEN2B requires an early diagnosis 
and treatment. It is critical that these cases are identi-
fi ed in the fi rst year of life so that early thyroidectomy is 
performed. When available, genetic analysis confi rms 
the diagnosis and guides pre-operative evaluation and 
extent of surgery (6).
Here we report four cases of MEN2B in which the 
late diagnosis had a signifi cant impact in clinical evolu-
tion and, potentially, in overall survival.
CASE REPORTS
First case
A 20 year-old man had a thyroid nodule diagnosed 
when he was 12 years old, following non-specifi c thro-
at complaints. He subsequently saw an endocrinolo-
gist who made the diagnosis of MTC through a serum 
calcitonin of 18750 pg/mL. He underwent total 
thyroidectomy at the age of 14, but only a partial re-
section was achieved. He then received systemic che-
motherapy with multiple drugs for four years and is 
now on imatinib (Gleevec®). During the treatment, 
one year after the thyroidectomy, lung nodules were 
found in a CT scan.
The past medical history was significant for seve-
re gastrointestinal obstruction requiring a surgery 
intervention two days after his birth and an ortho-
pedic surgery for a bone fracture after a fall at the 
age of 11. There was no family history of endocrine 
diseases.
In his last clinical visit, at the age of 20, the physical 
examination revealed a normal blood pressure, a wei-
ght of 43.8 kg, height of 181 cm with an arm span of 
175 cm and the presence of mucosal neuromas in the 
tongue. He brought a hip x-ray which showed femoral 
deformities (Figure 1A).
The genetic analysis revealed a mutation of the 
RET proto-oncogene, M918T (Figure 2A).
A B
C
Figure 1. A) Hip X-Ray of fi rst case showing a long and later-
ally-displaced femoral neck; B) fourth patient clinical char-
acteristics; C) mucosal neuromas in the tongue of fourth 
patient.
Figure 2. Eletropherograms of the reported cases with exon 
16 RET mutation at codon 918 (ATG>ACG).
Second case
A 23 year-old man with complaints of sweating, hyper-
tension (170 x 110 mmHg in more than one ocasion) 
and headache for 18 months was diagnosed with a ne-
arly fi ve-centimeter pheochromocytoma in the right 
adrenal gland and then underwent adrenalectomy. 
A B
C D
1396 Arq Bras Endocrinol Metab 2008;52/8































Prior to the surgery, on physical examination, a 
thyroid nodule was noticed. Thyroid ultrasound confi r-
med it to be a thyroid nodule in the right lobe, measu-
ring 1.4 cm in diameter and with central calcifi cation. 
Fine needle aspiration cytology confi rmed a MTC. 
Three months after the adrenalectomy, the patient un-
derwent total thyroidectomy with bilateral neck dissec-
tion and pathology revealed a multifocal medullary 
carcinoma with lymph-node involvement and extra-
thyroidal extension.
Upon questioning, he told he had nodules in the 
oral mucosa and constipation since childhood. On phy-
sical examination mucosal neuromas in the tongue 
were observed and there were no other remarkable fe-
atures. 
He was then submitted to close clinical follow-up. 
An abdominal CT scan revealed bilateral nephrolithia-
sis and an enlarged colon. A MIBG scintigraphy sho-
wed high uptake in left adrenal gland. To better 
investigate the MIBG fi ndings, a magnetic resonance 
imaging (MRI) was obtained which revealed a 1.1 cm 
nodule in the left adrenal gland with characteristics of a 
pheochromocytoma. A left adrenalectomy was perfor-
med confi rming a pheochromocytoma.
He also had a femoral fracture after an accident.
The DNA analysis revealed a mutation of the co-
don 918 of the RET oncogene (M918T) (Figure 
2B).
Third case
A 21 year-old woman presented a thyroid nodule at the 
age of 16, which was diagnosed as a medullary thyroid 
carcinoma. She underwent a total thyroidectomy and 
pathology revealed multifocal medullary thyroid carci-
noma (largest lesion measuring 4.5 x 2.7 cm) associa-
ted with  extra-thyroidal invasion, C cell hyperplasia 
and lymph-node involvement. 
Several months later she was found to have locally-
recurrent disease and underwent a limited neck dissec-
tion with removal of a small number of lymph-nodes. 
Post-operatively, due to the persistence of high serum 
calcitonin levels, she was treated with external-beam 
radiotherapy. 
Three years later, she complained of diarrhea and 
weakness. At this time serum calcitonin was signifi can-
tly abnormal (18004 pg/mL) and a CT scan of the 
chest revealed multiple nodules in the lungs confi rmed 
to be metastatic MTC by a biopsy. Prior to the referral 
to our institution, she underwent a left cervical neck 
dissection which failed to identify metastatic lymph-
nodes. 
She was then referred to our institution for further 
evaluation and management. Upon questioning she 
admitted to have had episodes of headache, palpitations 
and sweating lasting approximately three minutes, two 
to three times a week. In addition, she referred a his-
tory of constipation from birth until 5 months of life. 
There is no family history of medullary thyroid carcino-
ma, however, her father died at a young age from an 
unknown cause.
On physical examination, the blood pressure was 
120 x 70 mmHg (lying) and 100 x 70 mmHg (stan-
ding up), height was 171 cm, her arm span was 170 
cm. Other remarkable features included a thin and 
elongated face, thickened lips and  mucosal neuromas 
in the tongue. 
The laboratory evaluation included high levels of 
calcitonin (> 20.000 pg/mL) and CEA (423.7 µg/L) 
and normal levels of PTH and calcium. The urinary 
metanephrines were measured twice and total metane-
phrines were found to be elevated (1954 µg/24h and 
1556 µg/24h, normal values 95 to 425 µg/24h). 
A MIBG scan revealed moderate adrenal uptake, 
more intense in the left adrenal gland. MRI found sli-
ght thickening of both the adrenal glands with no spe-
cifi c lesions indicating a pheochromocytoma. Due to 
evidence of catecholamine hyper secretion without the 
localization of a pheochromocytoma, she was started 
on prazosin 1 mg/day and she has remained clinically 
stable. 
Additionally, the MRI revealed liver lesions suspi-
cious for metastasis and a vertebral lesion also suspi-
cious for metastatic disease. A recent neck ultrasound 
revealed a mass in the left thyroid bed measuring 27x16 
mm and two suspicious lymph nodes in the right cervi-
cal area. Due to the fi nding of progressive and widely 
metastatic disease she is under evaluation for systemic 
therapy. 
The DNA analysis revealed a M918T RET muta-
tion (Figure 2C).
Fourth case 
A 46 year-old woman was diagnosed with a thyroid no-
dule 30 years ago. She was treated with total thyroidec-
tomy and cervical dissection and received external-beam 
radiotherapy one year later. 
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The patient was recently evaluated at our institu-
tion and she then complained of weight loss, diarrhea 
(10 bowel movements a day) and dyspnea in the past 
year and a half. Before the diarrhea started she had 
chronic constipation (since childhood). In the past four 
weeks she had been having paroxysmal hypertension 
which led her to increase the anti-hypertensive drugs 
dosage by her own. Systolic blood pressure levels varied 
from 200 mmHg to 50 mmHg and during the hyper-
tensive episodes she describes that she felt “as her chest 
was going to explode”.  In addition, she refers that she 
has been evaluated by an ophthalmologist who obser-
ved “a MEN-related eye manifestation”.
The family history is signifi cant for a grandmother 
with history of a goiter, mother who died from diabetes 
complications at age 83 and a father who died from 
hypertension at the age of 87. She has a 16 year-old 
daughter who is healthy and apparently has no thyroid 
disease.
Physical examination fi ndings were orthostatic hy-
potension (140 x 90 mmHg lying and 90 x 70 mmHg 
standing), height of 1.72m and an arm span of 1.62m, 
an elongated face with thickened lips and mucosal neu-
romas in the tongue (Figures 1B and 1C).
Laboratory evaluation revealed a high serum calci-
tonin level (2800 pg/mL), an elevated CEA (132 
µg/L) and elevated urinary metanephrines.
MRI found multiples nodules in right lobe of the 
liver, cholelithiasis, a mass in the right adrenal gland 
measuring 11,7 cm and a mass in the left adrenal mea-
suring 4.7 cm. A CT scan of the chest showed diffuse 
interstitial  lung abnormalities which are under diag-
nostic evaluation .
DNA analysis revealed a M918T RET mutation 
(Figure 2D).
The patient was started on prazosin 1 mg/day and 
her blood pressure levels are now normal. She is cur-
rently under evaluation and preparation for bilateral 
adrenalectomy.
DISCUSSION
New concepts have emerged since the RET proto-on-
cogene was identifi ed in 1993 as the responsible gene 
for hereditary medullary thyroid carcinoma. The iden-
tifi cation of the genotype-phenotype correlations in-
cluding age-related development of disease, association 
with other manifestations such as pheochromocytoma 
and hyperparathyroidism and the codon-specifi c ag-
gressiveness of medullary thyroid carcinoma has enri-
ched the physician’s knowledge of the disease and 
facilitated the management of the individual patient 
and of kindreds with MEN2. Specifi cally, it has become 
clear that, for MEN2B patients, the chance for a better 
outcome is the early diagnosis and treatment and the 
proper screening of family members (9, 10).
The majority of MEN2B individuals have M918T 
mutation in exon 16, with a few cases having a muta-
tion A883F or the association of V804M with E805K, 
Y806C or S904C mutations (11-15). The consensus 
established in the last International Workshop on Mul-
tiple Endocrine Neoplasia classifi es the RET mutation 
in codon 918 as highest risk and recommends total 
thyroidectomy and central lymph node dissection until 
6 months after birth. A fast and precise diagnosis is es-
sential to reach these goals.
In this report, we describe four patients with 
MEN2B and incurable MTC due to late diagnosis. The 
diagnosis of MEN2B is frequent late, especially when 
there is no family history of MEN2B.  In newborns, the 
characteristic MEN2B phenotype is often absent and 
the only common manifestation is constipation due to 
intestinal ganglioneuromatosis. In fact, all our four pa-
tients with MEN2B had severe constipation during in-
fancy. It would be important to include MEN2B as a 
differential diagnosis of severe constipation and conge-
nital megacolon as, although rare, an early diagnosis of 
MEN2B could lead to appropriate treatment and po-
tential cure (6,16,17).
Other characteristics that could alert physicians of a 
MEN2B diagnosis include the fi nding of thickened 
corneal nerve upon an ophthalmologic evaluation as 
observed in patient 4 and the presence of skeletal mani-
festations such as scoliosis, kyphosis, lordosis, joint laxi-
ty, slipped capital femoral epiphyses and pes cavus 
(18-19). Although only one of the four patients has 
orthopedic complaints, the alterations may be common 
and guide the physician to the diagnosis of MEN2B.
The reported patients have characteristics such as 
the elongated face with thickened lips and mucosal 
neuromas, but not the classical marfanoid habitus, re-
presented by an arm span bigger than the height. The 
mucosal neuromas are the earliest signs and are present 
in almost all patients with MEN2B. Even in the absen-
ce of other signs or symptoms, the presence of mucosal 
neuromas in the early ages should motivate a MEN2B 
investigation.  
1398 Arq Bras Endocrinol Metab 2008;52/8































The complete syndrome with mucosal neuromas, 
pheochromocytoma and MTC occurs in only 50% of 
the cases and when present is already too late for a pro-
phylactic approach. The identifi cation of early manifes-
tations such as intestinal ganglioneuromatosis and oral 
mucosal neuromas should prompt the physician to ini-
tiate an investigation for multiple endocrine neoplasia 
type 2B. 
CONCLUSION
The diagnosis of MEN2B is very important to allow 
appropriate investigation of associated diseases and to 
allow counseling and appropriate screening of relatives 
for a RET mutation. Even patients with MEN2B, whi-
ch often have typical physical features, may not be pro-
perly recognized and be followed as a sporadic case. 
Based on this, all suspicious cases of multiple endocrine 
neoplasia should undergo a molecular genetic test.
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